Leukemia inhibitory factor protects against liver steatosis in nonalcoholic fatty liver disease patients and obese mice

Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide. However, the molecular mechanisms that promote dysregulation of hepatic triglyceride metabolism and lead to NAFLD are poorly understood, and effective treatments are limited. Leukemia inhibitory fact...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Youwen, Li, Kangli, Teng, Fei, Wang, Weiwei, Zhou, Bing, Zhou, Xuan, Lin, Jiayang, Ye, Xueru, Deng, Yajuan, Liu, Wenhui, Luo, Shenjian, Zhang, Peizhen, Liu, Deying, Zheng, Minghua, Li, Jin, Lu, Yan, Zhang, Huijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123280/
https://www.ncbi.nlm.nih.gov/pubmed/35447114
http://dx.doi.org/10.1016/j.jbc.2022.101946

Ejemplares similares

Ejemplares similares